» Articles » PMID: 17142317

Continuum of Prion Protein Structures Enciphers a Multitude of Prion Isolate-specified Phenotypes

Overview
Specialty Science
Date 2006 Dec 5
PMID 17142317
Citations 135
Authors
Affiliations
Soon will be listed here.
Abstract

On passaging synthetic prions, two isolates emerged with incubation times differing by nearly 100 days. Using conformational-stability assays, we determined the guanidine hydrochloride (Gdn.HCl) concentration required to denature 50% of disease-causing prion protein (PrP(Sc)) molecules, denoted as the [Gdn.HCl](1/2) value. For the two prion isolates enciphering shorter and longer incubation times, [Gdn.HCl](1/2) values of 2.9 and 3.7 M, respectively, were found. Intrigued by this result, we measured the conformational stabilities of 30 prion isolates from synthetic and naturally occurring sources that had been passaged in mice. When the incubation times were plotted as a function of the [Gdn.HCl](1/2) values, a linear relationship was found with a correlation coefficient of 0.93. These findings demonstrate that (i) less stable prions replicate more rapidly than do stable prions, and (ii) a continuum of PrP(Sc) structural states enciphers a multitude of incubation-time phenotypes. Our data argue that cellular machinery must exist for propagating a large number of different PrP(Sc) conformers, each of which enciphers a distinct biological phenotype as reflected by a specific incubation time. The biophysical explanation for the unprecedented plasticity of PrP(Sc) remains to be determined.

Citing Articles

SENP2-based N-terminal truncation of α-synuclein in Lewy pathology propagation.

Taguchi K, Watanabe Y, Tanaka M iScience. 2025; 28(2):111935.

PMID: 40028275 PMC: 11869972. DOI: 10.1016/j.isci.2025.111935.


Cofactors facilitate bona fide prion misfolding in vitro but are not necessary for the infectivity of recombinant murine prions.

Perez-Castro M, Perez-Castro M, Erana H, Vidal E, Charco J, Lorenzo N PLoS Pathog. 2025; 21(1):e1012890.

PMID: 39841704 PMC: 11774496. DOI: 10.1371/journal.ppat.1012890.


The dynamics of prion spreading is governed by the interplay between the non-linearities of tissue response and replication kinetics.

Fornara B, Igel A, Beringue V, Martin D, Sibille P, Pujo-Menjouet L iScience. 2024; 27(12):111381.

PMID: 39717079 PMC: 11664133. DOI: 10.1016/j.isci.2024.111381.


Chaperone-mediated disaggregation of infectious prions releases particles that seed new prion formation in a strain-specific manner.

Shoup D, Priola S J Biol Chem. 2024; 301(1):108062.

PMID: 39662829 PMC: 11758957. DOI: 10.1016/j.jbc.2024.108062.


Brain-derived and in vitro-seeded alpha-synuclein fibrils exhibit distinct biophysical profiles.

Lee S, Civitelli L, Parkkinen L Elife. 2024; 13.

PMID: 39584804 PMC: 11588339. DOI: 10.7554/eLife.92775.


References
1.
Supattapone S, Nguyen H, Cohen F, Prusiner S, Scott M . Elimination of prions by branched polyamines and implications for therapeutics. Proc Natl Acad Sci U S A. 1999; 96(25):14529-34. PMC: 24470. DOI: 10.1073/pnas.96.25.14529. View

2.
Criado J, Sanchez-Alavez M, Conti B, Giacchino J, Wills D, Henriksen S . Mice devoid of prion protein have cognitive deficits that are rescued by reconstitution of PrP in neurons. Neurobiol Dis. 2005; 19(1-2):255-65. DOI: 10.1016/j.nbd.2005.01.001. View

3.
Peretz D, Scott M, Groth D, Williamson R, Burton D, Cohen F . Strain-specified relative conformational stability of the scrapie prion protein. Protein Sci. 2001; 10(4):854-63. PMC: 2373967. DOI: 10.1110/ps.39201. View

4.
Prusiner S . Shattuck lecture--neurodegenerative diseases and prions. N Engl J Med. 2001; 344(20):1516-26. DOI: 10.1056/NEJM200105173442006. View

5.
Peretz D, Williamson R, Kaneko K, Vergara J, Leclerc E, Schmitt-Ulms G . Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature. 2001; 412(6848):739-43. DOI: 10.1038/35089090. View